Assays for Studying the Role of Vitronectin in Bacterial Adhesion and Serum Resistance
October 16th, 2018
7.2K views
This report describes protocols for characterizing interactions between bacterial outer membrane proteins and the human complement regulator vitronectin. The protocols can be used to study the binding reactions and biological function of vitronectin in any bacterial species.
Overview
This report describes protocols for characterizing interactions between bacterial outer membrane proteins and the human complement regulator vitronectin. The methods can help answer key questions in the host-pathogen interaction field.
Key Study Components
Area of Science
- Microbiology
- Immunology
- Host-pathogen interactions
Background
- Vitronectin is a host protein involved in the extracellular matrix.
- It functions as a complement inhibitor in the complement activation pathway.
- Understanding vitronectin's role is crucial for studying bacterial infections.
- This study focuses on how bacterial pathogens utilize human proteins to establish infections.
Purpose of Study
- To investigate the binding reactions between bacterial proteins and vitronectin.
- To explore the biological function of vitronectin in various bacterial species.
- To determine if pathogens can utilize vitronectin for infection.
Methods Used
- Flow cytometry to analyze bacterial interactions with vitronectin.
- Resuspension of bacterial pellets in blocking buffer with vitronectin.
- Incubation of samples at room temperature.
- Assessment of binding reactions and biological functions.
Main Results
- Protocols successfully characterize interactions between bacteria and vitronectin.
- Insights gained into the role of vitronectin in bacterial pathogenesis.
- Demonstrated the potential of pathogens to exploit human proteins.
- Provided a framework for future studies on host-pathogen interactions.
Conclusions
- The study highlights the importance of vitronectin in bacterial infections.
- Protocols can be applied to various bacterial species for further research.
- Understanding these interactions may lead to new therapeutic strategies.
Frequently Asked Questions
What is vitronectin?
Vitronectin is a human protein involved in the extracellular matrix and functions as a complement inhibitor.
How does this study contribute to understanding bacterial infections?
It explores how bacterial pathogens utilize human proteins like vitronectin to establish infections.
What methods are used in this research?
Flow cytometry and specific protocols for resuspending bacterial pellets with vitronectin are used.
Why is understanding host-pathogen interactions important?
It helps in developing new therapeutic strategies against bacterial infections.
Can these protocols be applied to different bacterial species?
Yes, the protocols are designed to be applicable to various bacterial species.
What are the main findings of this study?
The study successfully characterizes the interactions between bacterial proteins and vitronectin.
Executive Industry Relevance
Understanding how bacterial pathogens exploit host complement regulators like vitronectin provides critical mechanistic insights for anti-infective target validation. This assay framework enables de-risking of virulence factors by quantifying protein-protein interactions that contribute to immune evasion and adherence. The approach supports early discovery decisions by linking molecular binding to functional phenotypes in serum resistance and epithelial cell adhesion.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Interrogates therapeutic hypotheses regarding bacterial utilization of host proteins for immune evasion.
- Operational Value: Enables functional target validation of outer membrane proteins like protein H through direct binding assays.
- Scientific Value: Supports predictive confidence by correlating vitronectin binding with serum resistance phenotypes.
Screening & Assay Development
- Scientific Value: Prepares validated biological systems for downstream screening by characterizing ligand-receptor interactions.
- Operational Value: Delivers standardized, quantitative outputs via ELISA and bio-layer interferometry for assay reproducibility.
- Scientific Value: Facilitates screening readiness through adaptable protocols for vitronectin-coated surfaces and cellular adherence models.
Translational & Preclinical Research
- Scientific Value: Examines disease relevance by connecting vitronectin binding to complement inhibition and epithelial cell adherence.
- Operational Value: Ensures translational continuity from binding assays to functional outcomes in human serum and cell-based systems.
- Scientific Value: Informs risk-adjusted advancement decisions by identifying virulence factors that confer serum resistance.
Pipeline & Workflow Integration
The method integrates into early discovery workflows by progressing from molecular interaction screening to phenotypic validation in immune evasion and adhesion models.
- Discovery Biology: Supports hypothesis testing of pathogen-host protein interactions and pathway clarification of complement evasion.
- Screening: Delivers assay readiness through standardized vitronectin immobilization and quantitative binding measurements.
- Analytics: Provides kinetic affinity data (KD) and endpoint binding signals for comparative condition analysis.
- Translational Research: Connects target engagement to preclinical relevance via serum resistance and epithelial cell adherence models.
- Enterprise Reuse: Establishes a reusable platform for evaluating vitronectin recruitment across diverse bacterial pathogens.
Operational & Enterprise Impact
- Scientific Value: Predictive confidence in target validation through mechanistic de-risking of immune evasion mechanisms.
- Operational Value: Standardization and reproducibility across flow cytometry, ELISA, BLI, and cellular assays.
- Strategic Value: Improved go/no-go decisions by identifying virulence factors that enable serum survival.
- Portfolio Impact: Risk-adjusted prioritization of targets based on functional contribution to immune evasion.
Implementation Considerations
- Requires expertise in microbiology, immunology, and protein interaction assays.
- Depends on instrumentation for flow cytometry, microplate readers, and bio-layer interferometry systems.
- Necessitates cross-team standardization of vitronectin preparation and bacterial culture conditions.
- Involves adaptation considerations for different bacterial species and vitronectin sources.
- Practical limitations include dependency on functional vitronectin and access to human serum samples.
Biopharma FAQs
Why does vitronectin binding matter for target validation in bacterial pathogenesis?
Vitronectin binding enables bacterial immune evasion by inhibiting complement-mediated killing, making it a key virulence factor to validate. Demonstrating this interaction supports target prioritization by linking molecular binding to functional serum resistance phenotypes. This mechanistic insight reduces ambiguity in target selection for anti-infective development.
How does isolating the vitronectin-protein H interaction fit the antibacterial discovery pipeline?
Isolating the specific interaction between recombinant protein H and vitronectin using ELISA and BLI enables de-risking of target engagement early in discovery. This reduction of mechanistic ambiguity supports hypothesis-driven screening of inhibitors or antibodies that block the interaction. The quantitative binding data informs lead identification by establishing structure-activity relationships for intervention strategies.
What quantitative measurements from bio-layer interferometry enable predictive confidence in target engagement?
Bio-layer interferometry provides real-time kinetic analysis, yielding an affinity (KD) of 2.2 micromolar for the protein H-vitronectin interaction. This quantitative output allows comparison across mutants, inhibitors, or alternative ligands to assess binding specificity and strength. Such measurements support go/no-go decisions by defining benchmarks for target engagement in downstream validation.
Why do replication requirements in serum resistance assays matter for cross-functional collaboration?
Replication in serum resistance assays using normal and vitronectin-depleted human serum ensures reproducible demonstration of immune evasion phenotypes. Consistent results across experiments build confidence in target validity when shared between microbiology, immunology, and pharmacology teams. This reproducibility supports reliable data transfer for lead optimization and preclinical development planning.
What statistical analysis capabilities are required before implementing vitronectin binding assays in a discovery workflow?
Implementation requires capability to calculate percentage survival from colony counts in serum resistance assays and to analyze fluorescence shifts in flow cytometry data. Statistical comparison between wild-type and mutant strains is necessary to establish significant differences in vitronectin binding and functional outcomes. These analyses ensure that observed effects are robust and not due to experimental variability, supporting data-driven target validation.
Chapters in this video
0:04
Title
0:49
Detection of Vitronectin (Vn) Binding at the Bacterial Surface Using Flow Cytometry
2:18
ELISA Analysis of the Interaction Between Recombinant Protein H (PH) and Vn
4:11
Study of the Interaction Kinetics of Recombinant PH and Vn Using Bio-layer Interferometry
4:33
Bacterial Adherence to the Vn-coated Glass Surfaces
5:32
Vn-dependent Adherence of Bacteria to Epithelial Cells
7:29
Analysis of Vn-dependent Resistance to the Bactericidal Activity of Human Serum
8:29
Results: Interaction of Vitronectin and Bacteria
10:10
Conclusion
